6 其他想留 34,542 - (129) 8,000 本公司為投資控股公司。本公司及其附屬公司(統稱「本集團」)主要從事(1)透過設 於香港及中華人民共和國(「中國內地」)廣東省不同地點的自助身份證明(「身份證 明」)照片數碼快相機提供攝影服務：及(ii)於香港透過經營醫務中心提供醫療服務。 未經審核簡明綜合財務報表附註 於香港提供醫療服務 13 ​​​ 本公司董事(「董事」)會(「董事會」)欣然呈列本公司及其附屬公司(統稱「本集團」)截至 二零二三年三月三十一日止三個月(「報告期」）的未經審核簡明綜合業績連同有開比較數 據如下： 截至二零二三年三月三十一日止三個月 千禧元 - - .. 名仕快相集團控股有限公司 / 2023 年第一季度報告 未經審核簡明綜合財務報表附註 未經審核簡明綜合財務報表附註 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------|-------------------|---------------------|-------------------|----------- ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本 公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確 表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何責任。 本公告載有遵照聯交所GEM證券上市規則（「GEM上市規則」）提供的詳情， 旨在提供關於名仕快相集團控股有限公司（「本公司」，連同其附屬公司， 統稱「本集團」或「我們」）的資料，本公司董事（「董事」）就此共同及個別地 承擔全部責任。董事經作出一切合理查詢後確認，就彼等所深知及確信， 本公告所載資料在所有重大方面均屬準確及完整，並無誤導或欺詐成分， 且本公告並無遺漏任何其他事宜導致當中任何陳述或本公告具誤導成分。 Max Sight Photo (cid:8907)(cid:7571)(cid:11945)(cid:17846) Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 三 年 三 月 三 十 一 日 止 三 個 月 第 一 季 度 業 績 公 ...

股份計劃 本公司購股權計劃（「購股權計劃」）已於二零一八年二月八日獲股東根據一項書面決議案採納。於截至二零二二 年十二月三十一日止年度，購股權計劃項下概無本公司購股權獲授出、失效、行使或註銷，且於二零二二年 十二月三十一日，並無尚未行使的購股權。 1. 目的 購股權計劃旨在鼓勵合資格人士（定義見下文第 (2)段）於日後對本集團作出最佳貢獻；及╱或獎勵彼等過往 作出之貢獻、吸納及留聘對本集團重要及╱或其貢獻對本集團之業績、增長或成就確屬或將會有所裨益之 合資格人士或與彼等維持持續之關係；此外，就行政人員之情況而言，亦有助本集團吸納及挽留有經驗及 能幹之人士及╱或獎勵彼等過往作出之貢獻。 2. 合資格人士 董事會可全權酌情邀請本集團任何成員公司之任何董事或建議董事（包括獨立非執行董事）、任何執行董 事、經理或在本集團任何成員公司擔任行政、管理、監督或類似職位之其他僱員（「僱員」）、任何建議僱 員、任何全職或兼職僱員、或當時派調本集團任何成員公司全職或兼職工作之任何人士、本集團任何成員 公司之顧問、業務或合營夥伴、特許經營商、承包商、代理或代表、或向本集團任何成員公司提供任何諮 詢、顧問、專業或其他服務之個人或實體 ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而 引致的任何損失承擔任何責任。 本公告載有遵照聯交所GEM證券上市規則（「GEM上市規則」）提供的詳情，旨在提供關於名仕快相集團控 股有限公司（「本公司」）的資料，本公司董事（「董事」）就此共同及個別地承擔全部責任。董事經作出一切合 理查詢後確認，就彼等所深知及確信，本公告所載資料在所有重大方面均屬準確及完整，並無誤導或欺詐 成分，且本公告並無遺漏任何其他事宜導致當中任何陳述或本公告具誤導成分。 Max Sight Photo Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 年 度 業 績 公 告 聯 交 所 GEM 的 特 色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上市 的公司帶有較高投資風險。有 ...

Max Sight Photo 名仕快相 名仕快相集團控股有限公司 (於開曼群島註冊成立的有限公司) 股份代號 : 8483 2022 第三季度業績報告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上 市的公司帶有較高投資風險。有意投資者應了解投資於該等公司的潛在風險，並應經 過審慎周詳考慮後方作出投資決定。 由於 GEM上市公司普遍為中小型公司，在 GEM買賣的證券可能會較於聯交所主板買 賣的證券承受較大的市場波動風險，同時亦無法保證在 GEM買賣的證券會有高流通量 的市場。 香港交易及結算所有限公司及聯交所對本季度報告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本季度報告全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 本季度報告的資料乃遵守聯交所GEM證券上市規則（「GEM上市規則」）而刊載，旨在 提供有關名仕快相集團控股有限公司（「本公司」，連同其附屬公司為「本集團」或「我 們」）的資料；本公司董事（「董事」）願就本季度報告的資料共同及個別地承擔全部責 任。各董事於作出一 ...

Revenue and Business Segments - The group's revenue increased from approximately HKD 9,232,000 for the six months ended June 30, 2021, to approximately HKD 11,455,000 for the six months ended June 30, 2022, representing an increase of about 24.0%[6] - Medical services revenue was approximately HKD 3,016,000 for the six months ended June 30, 2022, which was not present in the same period in 2021, indicating a new business segment launched in October 2021[6] - The group operates three reportable segments: photography services in Hong Kong, photography services in Mainland China, and medical services in Hong Kong[36] - The revenue from external customers in Hong Kong was HKD 10,951,000, an increase from HKD 8,535,000 in the previous year, while revenue from mainland China decreased to HKD 504,000 from HKD 697,000[40] - The company continues to focus on expanding its medical services, which began in October 2021, indicating a strategic shift towards healthcare[33] Financial Performance - Loss attributable to equity shareholders increased from approximately HKD 3,050,000 for the six months ended June 30, 2021, to approximately HKD 6,434,000 for the six months ended June 30, 2022, primarily due to increased gross loss and administrative expenses[6] - The total comprehensive loss for the six months ended June 30, 2022, was HKD 6,702,000, compared to a loss of HKD 3,133,000 for the same period in 2021, representing an increase in loss of 114%[12] - The basic and diluted loss per share for the period was HKD 0.80, compared to HKD 0.38 in the previous year, indicating a 105% increase in loss per share[12] - The group reported a loss before tax of approximately HKD 6,960,000 for the six months ended June 30, 2022, compared to HKD 3,081,000 for the same period in 2021[11] - The company reported a pre-tax loss of HKD 6,960,000 for the period, compared to a pre-tax loss of HKD 3,081,000 in the prior year[37] Operating Expenses - The group's gross loss and gross profit for the six months ended June 30, 2022, were approximately HKD 497,000 and HKD 2,161,000, respectively, with gross loss margin and gross profit margin at approximately 4.34% and 23.41%[6] - Administrative expenses increased due to higher employee costs and director remuneration associated with the medical services business launched in Hong Kong[6] - The total operating expenses, including headquarters and corporate costs, amounted to HKD 5,393,000, compared to HKD 5,825,000 in the previous year[37] - Administrative expenses rose from approximately HKD 6,320,000 for the six months ended June 30, 2021, to approximately HKD 8,245,000 for the six months ended June 30, 2022, an increase of about 30.5%[82] Assets and Liabilities - Non-current assets increased to HKD 29,471,000 as of June 30, 2022, from HKD 26,496,000 as of December 31, 2021, reflecting an increase of 11.8%[14] - Current assets decreased to HKD 25,631,000 as of June 30, 2022, from HKD 33,291,000 as of December 31, 2021, a decline of 23.1%[14] - The company’s total liabilities increased to HKD 14,603,000 as of June 30, 2022, from HKD 14,856,000 as of December 31, 2021, a decrease of 1.7%[15] - The company’s equity attributable to shareholders decreased to HKD 28,622,000 as of June 30, 2022, from HKD 34,784,000 as of December 31, 2021, a decline of 17.7%[15] - The company’s inventory increased to HKD 533,000 as of June 30, 2022, from HKD 148,000 as of December 31, 2021, an increase of 259.5%[14] Employee and Workforce - As of June 30, 2022, the group had 65 employees, an increase from 36 employees as of June 30, 2021, representing an 81.25% growth in workforce[89] - The total employee costs reached HKD 6,654,000, up from HKD 4,293,000 in the previous year, reflecting a 55% increase[43] Corporate Governance and Compliance - The financial statements were prepared in accordance with Hong Kong Financial Reporting Standards and have been reviewed by the audit committee[28] - The audit committee has reviewed the unaudited consolidated results for the six months ended June 30, 2022, ensuring compliance with applicable accounting standards and regulations[119] - The company has complied with all applicable provisions of the corporate governance code during the six months ended June 30, 2022[99] Future Plans and Strategic Initiatives - The group is exploring opportunities to diversify its business and is reallocating resources to optimize its business model for future growth[74] - The group plans to adopt a more cautious approach in executing its expansion plans in mainland China due to the ongoing COVID-19 situation and market volatility[70] - The company is actively seeking to recruit suitable medical professionals and expand its medical services business through new clinics and related operations[125] Impact of COVID-19 - The company reported a significant impact on financial performance due to the ongoing COVID-19 pandemic, with further economic conditions remaining uncertain[67] - Photography service revenue decreased by approximately 8.59% to about HKD 8,439,000 for the six months ended June 30, 2022, compared to HKD 9,232,000 for the same period in 2021, primarily due to reduced travel demand caused by the COVID-19 pandemic[76] - The company has delayed its original plan to expand the digital photo booth network in Guangdong due to challenges posed by the COVID-19 pandemic and the Omicron variant outbreak[125] Share Capital and Major Shareholders - The issued share capital of the company remained unchanged since its listing date, with a total of 800,000,000 shares issued[88] - The major shareholders, Mr. Chan Wing Chai and Mr. Chan Tin Ki, each hold 53.45% of the company's shares[104] - As of June 30, 2022, Causeway Treasure holds 427,600,560 shares, representing approximately 53.45% of the company's equity[111] - Photo-Me holds 109,972,500 shares, accounting for 13.75% of the company's equity[111] Use of Proceeds - The company raised approximately HKD 62.0 million from the sale of 200,000,000 shares at HKD 0.31 per share[120] - As of June 30, 2022, approximately HKD 12.9 million of the net proceeds has been utilized, with HKD 19.0 million remaining[123] - The company plans to use HKD 6.1 million for the development of its self-service identity photo digital camera business by December 31, 2023[123] - An allocation of HKD 4.6 million is designated for purchasing equipment for medical and related services by December 31, 2023[123] - The company aims to establish or acquire new clinics and medical-related businesses with an allocation of HKD 2.0 million by December 31, 2023[123] - Upgrading verification centers and IT infrastructure has an allocation of HKD 2.0 million, with HKD 0.9 million already utilized[123] - General working capital has an allocation of HKD 10.2 million, with HKD 5.0 million already utilized[123]

Financial Performance - The group's revenue decreased by approximately HKD 327,000 to about HKD 4,103,000 for the three months ended March 31, 2022, compared to HKD 4,430,000 for the same period in 2021[6]. - Photography service revenue dropped by approximately 45.98% to about HKD 2,393,000 for the three months ended March 31, 2022, down from HKD 4,430,000 for the same period in 2021[6]. - Medical services revenue was approximately HKD 1,710,000 for the three months ended March 31, 2022, starting from October 2021 when the company began operating medical centers in Hong Kong[6]. - The company's revenue decreased from approximately HKD 4,430,000 for the three months ended March 31, 2021, to approximately HKD 4,103,000 for the three months ended March 31, 2022, a decline of about 7.38%[46]. - Revenue from photography services for the three months ended March 31, 2022, was HKD 2,393 thousand, down 46% from HKD 4,430 thousand in the same period of 2021[24]. - Revenue from medical services for the three months ended March 31, 2022, was HKD 1,710 thousand, with no revenue reported in the same period of 2021[24]. - Total revenue for the group for the three months ended March 31, 2022, was HKD 4,103 thousand, a decrease of 7% compared to HKD 4,430 thousand in the same period of 2021[24]. - Revenue from Hong Kong was HKD 3,831 million, down 6.0% from HKD 4,074 million year-on-year[30]. - Revenue from Mainland China was HKD 272 million, a decline of 23.6% compared to HKD 356 million in the previous year[30]. Loss and Expenses - The group's gross loss and gross profit for the three months ended March 31, 2022, were approximately HKD 901,000 and HKD 421,000, respectively, with gross loss margin and gross profit margin at approximately 21.96% and 9.50%[6]. - Loss attributable to equity shareholders increased by approximately HKD 2,062,000 to about HKD 3,735,000 for the three months ended March 31, 2022, compared to HKD 1,673,000 for the same period in 2021[6]. - Operating loss for the three months ended March 31, 2022, was approximately HKD 3,732,000, compared to HKD 1,616,000 for the same period in 2021[11]. - The company reported a net loss of HKD 3,864,000 for the three months ended March 31, 2022, compared to HKD 1,673,000 for the same period in 2021[11]. - The total comprehensive loss for the three months ended March 31, 2022, was HKD (3,909) thousand, compared to a loss of HKD (1,668) thousand in the same period of 2021[12]. - Basic and diluted loss per share for the period was HKD (0.47), compared to HKD (0.21) in the previous year[12]. - The group reported a loss before tax of HKD 3,863 million for the quarter, compared to a loss of HKD 1,692 million in the same period last year[30]. - The company reported a loss attributable to equity shareholders of approximately HKD 3,735,000 for the three months ended March 31, 2022, up from HKD 1,673,000 for the same period in 2021, marking an increase of about 123.56%[55]. Impact of COVID-19 - The COVID-19 pandemic has significantly impacted the financial performance and business development of the group, particularly affecting the demand for identity photos[37]. - The increase in loss was primarily due to higher gross loss from the impact of the fifth wave of COVID-19 in Hong Kong and increased administrative expenses due to higher employee costs and director remuneration related to the medical services business[6]. - The management believes that the decline in demand for identity photos is temporary and expects a recovery in the near future as vaccination rates increase[40]. - The group plans to continue monitoring the COVID-19 situation and has taken measures to mitigate its impact on financial conditions and operational performance[41]. - The company has reported delays in business development in Guangdong Province and Hong Kong due to the COVID-19 pandemic and macroeconomic uncertainties[97]. Administrative and Operational Changes - Administrative expenses increased from approximately HKD 3,130,000 for the three months ended March 31, 2021, to approximately HKD 4,173,000 for the same period in 2022, an increase of about 33.33%[52]. - The company has terminated underperforming lease agreements for photo booths as a cost-control measure[41]. - The company is reallocating more funds and resources towards IT infrastructure to optimize its business model and achieve diversification in core operations[43]. - The company is enhancing its IT capabilities to meet future business trends and customer demands, including upgrading its IT infrastructure and payment systems[96]. Medical Services Expansion - The company is expanding its medical services business, aiming to further develop its medical network in Hong Kong by the end of 2022[44]. - The company has initiated various outreach vaccination services to provide flexible vaccination channels to the public[44]. - The company is actively recruiting suitable practitioners and locations to expand its medical services business further[44]. - The company commenced providing medical services through medical centers in Hong Kong starting October 2021[22]. Corporate Governance and Compliance - The company has maintained compliance with all applicable corporate governance codes as of March 31, 2022[69]. - All directors confirmed compliance with the trading standards for securities transactions during the three months ending March 31, 2022[70]. - The audit committee has reviewed the unaudited consolidated results for the three months ended March 31, 2022, confirming compliance with applicable accounting standards and GEM listing rules[91]. Shareholder Information - The major shareholder, Causeway Treasure, holds approximately 53.45% of the company's shares[83]. - The company has not declared any interim dividend for the periods ended March 31, 2022, and March 31, 2021[33]. - The company has not made any significant investments or future plans regarding major investments and capital assets as of March 31, 2022[62]. - There were no major acquisitions or disposals of subsidiaries, associates, or joint ventures during the period ending March 31, 2022[63]. - The company has not pledged any assets as of March 31, 2022[64]. - There are no significant contingent liabilities reported as of March 31, 2022[65]. - The company did not purchase, sell, or redeem any of its listed securities during the three months ending March 31, 2022[71]. - The company has not disclosed any new product or technology developments, market expansions, or mergers and acquisitions during the reporting period[62][63][64][65]. Utilization of Proceeds - As of March 31, 2022, the company has utilized approximately HKD 10,546,000 of the net proceeds from the share sale, with a remaining unutilized amount of HKD 21,306,000[92]. - The company plans to expand its self-service identity photo digital camera network in Guangdong Province, with HKD 24,381,000 allocated for this purpose, of which HKD 6,652,000 has been used[94]. - The company has reassigned approximately HKD 5,000,000 from the unutilized proceeds for general working capital due to challenges in expanding the self-service identity photo digital camera market in Guangdong Province[97]. - All unutilized proceeds are currently held in a licensed bank in Hong Kong[99].

Financial Performance - For the fiscal year ending December 31, 2021, the company generated revenue of approximately HKD 20,953,000, while the attributable loss to owners was about HKD 7,408,000, primarily due to the outbreak of the COVID-19 pandemic[13]. - The group's financial performance deteriorated mainly due to weak revenue for the year ended December 31, 2021, attributed to the COVID-19 pandemic and travel restrictions, leading to a significant decline in demand for identification photos[17]. - The company's revenue increased from approximately HKD 19,979,000 for the year ended December 31, 2020, to approximately HKD 20,953,000 for the year ended December 31, 2021, representing an increase of about 4.9%[31]. - Photography service revenue slightly rose by approximately 1.7% to about HKD 20,311,000 for the year ended December 31, 2021, compared to HKD 19,979,000 in 2020[31]. - Medical services revenue was approximately HKD 642,000 for the year ended December 31, 2021, compared to none in 2020, indicating the commencement of medical service operations[31]. - Gross profit increased to approximately HKD 5,184,000 for the year ended December 31, 2021, with a gross profit margin of about 24.74%, up from HKD 1,757,000 and a margin of 8.79% in 2020[33]. - Administrative expenses rose from approximately HKD 11,813,000 in 2020 to about HKD 14,043,000 in 2021, an increase of about 18.9% primarily due to higher employee costs[36]. - The loss attributable to equity shareholders increased from approximately HKD 4,478,000 in 2020 to about HKD 7,408,000 in 2021, reflecting a rise of approximately 65.4%[42]. Business Expansion and Diversification - The company has expanded its business portfolio by launching medical services in October 2021, operating four medical centers in Hong Kong, and plans to establish more centers by the end of 2022[12]. - The company is reallocating resources to enhance its IT infrastructure and optimize its business model, aiming for diversification in its core photography services[11]. - The company aims to explore new business opportunities for sustainable growth and to create long-term value for shareholders[12]. - The group established four subsidiaries to launch its medical services business in Hong Kong as of December 31, 2021, employing approximately 24 staff and professionals[18]. - The company is actively recruiting suitable practicing doctors and locations to further expand its medical services business[31]. - The company is exploring opportunities in Guangdong Province and other regions in mainland China to expand its self-service identity photo digital kiosk network[58]. - The company has registered four subsidiaries to develop its medical services business as part of its diversification strategy[31]. Impact of COVID-19 - The ongoing COVID-19 pandemic has introduced additional uncertainties in the photography service market and operational environment[11]. - The group has faced challenges due to the ongoing COVID-19 pandemic and changing government policies in mainland China affecting its business operations[28]. - The group has taken measures to mitigate the impact of the pandemic, including seeking fee reductions and better terms from suppliers[17]. - The demand for identification photos is expected to recover as the COVID-19 situation improves, with the group actively monitoring the pandemic's impact on its financial performance[23]. - The company is closely monitoring the ongoing COVID-19 situation and its potential impact on financial performance and operational results[68]. Corporate Governance and Compliance - The company has adopted high standards of corporate governance practices as detailed in the annual report[176]. - The group has complied with all relevant laws and regulations, with no significant violations reported that could impact business operations[105]. - The board of directors consists of three executive directors, two non-executive directors, and three independent non-executive directors as of the report date[188]. - The company has established a board diversity policy to enhance performance by considering various factors such as gender, age, cultural background, and professional experience[190]. - The board aims to nominate at least one female candidate for board membership within the next two financial years to improve gender diversity[191]. - The company has implemented appropriate liability insurance for directors, which is reviewed annually[187]. - The company confirmed compliance with the non-competition agreements established by major shareholders for the year ended December 31, 2021[165]. Future Outlook and Strategic Initiatives - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[75]. - New product launches are expected to contribute an additional HKD 300 million in revenue over the next fiscal year[74]. - The company is investing HKD 50 million in R&D for new imaging technologies, aiming to enhance product offerings[78]. - A strategic acquisition of a local competitor is anticipated to be finalized by Q2 2024, expected to increase market penetration by 10%[79]. - The company has set a performance guidance of 10% revenue growth for the upcoming fiscal year[76]. Shareholder Relations and Dividends - The board of directors has decided not to recommend any final dividend for the fiscal year ending December 31, 2021, to maintain sufficient funds for future business development[16]. - The company did not recommend the declaration of any interim or final dividends for the year ended December 31, 2021[69]. - The group has a distributable reserve of approximately HKD 14,357,000 as of December 31, 2021, with no final dividend declared for the year[117]. - The board of directors has approved a dividend payout of HKD 0.10 per share, reflecting a commitment to returning value to shareholders[82]. Operational Efficiency and Risk Management - The company is committed to strengthening its core business while seizing market opportunities for future development[12]. - The company relies on a professional team for its medical services, and any failure to attract or retain qualified professionals could adversely affect financial performance[100]. - The company has established standard operating procedures for its medical centers to minimize risks associated with medical negligence[101]. - The company’s business, operational performance, and financial condition may be impacted by various risks and uncertainties related to its operations[97]. - The group has implemented business continuity plans including "work from home," "flexible hours," and "group arrangements" to mitigate the impact of natural disasters or pandemics on operations[102].

Max Sight Photo 名仕快相 名仕快相集團控股有限公司 (於開曼群島註冊成立的有限公司) 股份代號 : 8483 第 三季度業績報告 香港聯合交易所有限公司(「聯交所」) GEM 的特色 GEM 的定位,乃為中小型公司提供一個上市的市場,此等公司相比起其他在聯交所上 市的公司帶有較高投資風險。有意投資者應了解投資於該等公司的潛在風險,並應經過 審慎周詳考慮後方作出投資決定。 由於 GEM 上市公司普遍為中小型公司,在 GEM 買賣的證券可能會較於聯交所主板買賣 的證券承受較大的市場波動風險,同時亦無法保證在GEM買賣的證券會有高流通量的 市場。 香港交易及結算所有限公司及聯交所對本季度報告的內容概不負責,對其準確性或完整 性亦不發表任何聲明,並明確表示概不就因本季度報告全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 本季度報告的資料乃遵守聯交所GEM證券上市規則(「GEM上市規則」)而刊載，旨在提 供有關名仕快相集團控股有限公司(「本公司」,連同共附屬公司為「本集團」或「我們」) 的資料:本公司董事(「董事」)願就本季度報告的資料共同及個別地承擔全部責任。各董 事於作出一 ...

Max Sight Photo 名仕快相 名仕快相集團控股有限公司 (於開曼群島註冊成立的有限公司) 股份代號 : 8483 中 期 報告 香港聯合交易所有限公司(「聯交所」) GEM 的特色 GEM 的定位,乃為中小型公司提供一個上市的市場,此等公司相比起其他在聯交所上 市的公司帶有較高投資風險。有意投資者應了解投資於該等公司的潛在風險,並應經過 審慎周詳考慮後方作出投資決定。 由於 GEM 上市公司普遍為中小型公司,在 GEM 買賣的證券可能會較於聯交所主板買賣 的證券承受較大的市場波動風險,同時亦無法保證在GEM買賣的證券會有高流通量的 市場。 香港交易及結算所有限公司及聯交所對本中期報告的內容概不負責,對其準確性或完整 性亦不發表任何聲明,並明確表示概不就因本中期報告全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 本中期報告的資料乃遵守聯交所GEM證券上市規則(「GEM上市規則」)而刊載，旨在提 供有關名仕快相集團控股有限公司(「本公司」,連同共附屬公司為「本集團」或「我們」) 的資料:本公司董事(「董事」)願就本中期報告的資料共同及個別地承擔全部責任。各董 事於作出一切合理 ...